These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 25072153)
21. Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat: focus on serum, urine, gene, and protein renal expression biomarkers. Sereno J; Nunes S; Rodrigues-Santos P; Vala H; Rocha-Pereira P; Fernandes J; Santos-Silva A; Teixeira F; Reis F Biomed Res Int; 2014; 2014():576929. PubMed ID: 24971338 [TBL] [Abstract][Full Text] [Related]
22. Allicin ameliorates kidney function and urinary bladder sensitivity in cyclosporine A-treated rats. El-Kashef DH; El-Kenawi AE; Suddek GM; Salem HA Hum Exp Toxicol; 2017 Jul; 36(7):681-691. PubMed ID: 27596067 [TBL] [Abstract][Full Text] [Related]
23. One dose of cyclosporine A is protective at initiation of folic acid-induced acute kidney injury in mice. Wen X; Peng Z; Li Y; Wang H; Bishop JV; Chedwick LR; Singbartl K; Kellum JA Nephrol Dial Transplant; 2012 Aug; 27(8):3100-9. PubMed ID: 22294776 [TBL] [Abstract][Full Text] [Related]
25. Suppression of cyclosporine a nephrotoxicity in vivo by transforming growth factor beta receptor-immunoglobulin G chimeric protein. Xin J; Homma T; Matsusaka T; Ma J; Isaka Y; Imai E; Ichikawa I Transplantation; 2004 May; 77(9):1433-42. PubMed ID: 15167603 [TBL] [Abstract][Full Text] [Related]
26. Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity. Padi SS; Chopra K Pharmacol Res; 2002 May; 45(5):413-20. PubMed ID: 12123630 [TBL] [Abstract][Full Text] [Related]
27. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Hagar HH; El Etter E; Arafa M Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):189-96. PubMed ID: 16487261 [TBL] [Abstract][Full Text] [Related]
28. Effects of cyclosporine in osteopontin null mice. Mazzali M; Hughes J; Dantas M; Liaw L; Steitz S; Alpers CE; Pichler RH; Lan HY; Giachelli CM; Shankland SJ; Couser WG; Johnson RJ Kidney Int; 2002 Jul; 62(1):78-85. PubMed ID: 12081566 [TBL] [Abstract][Full Text] [Related]
30. Effect of FTY720 on chronic cyclosporine nephropathy in rats. Kim JY; Lim SW; Li C; Kim JS; Ahn KO; Yang HJ; Choi BS; Kim YS; Kim J; Bang BK; Yang CW Transplantation; 2005 Nov; 80(9):1323-30. PubMed ID: 16314802 [TBL] [Abstract][Full Text] [Related]
31. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats. Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305 [TBL] [Abstract][Full Text] [Related]
32. Identification of novel indicators of cyclosporine A nephrotoxicity in a CD-1 mouse model. O'Connell S; Slattery C; Ryan MP; McMorrow T Toxicol Appl Pharmacol; 2011 Apr; 252(2):201-10. PubMed ID: 21354196 [TBL] [Abstract][Full Text] [Related]
33. Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia. Ahmed A; Huang L; Raftery AT; Ahmed AK; Fahmy H; El Nahas AM; Haylor JL Transplantation; 2004 Mar; 77(5):686-92. PubMed ID: 15021830 [TBL] [Abstract][Full Text] [Related]
34. Renal protective effects of leukotriene receptor blockers in an experimental model of cyclosporine nephrotoxicity. Atakan A; Arikan H; Macunluoglu B; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E Transplant Proc; 2008; 40(1):279-84. PubMed ID: 18261606 [TBL] [Abstract][Full Text] [Related]
35. The effect of low-dose Continuous Erythropoietin receptor activator in an experimental model of acute Cyclosporine A induced renal injury. Meerwein C; Korom S; Arni S; Inci I; Weder W; Jungraithmayr W Eur J Pharmacol; 2011 Dec; 671(1-3):113-9. PubMed ID: 21968143 [TBL] [Abstract][Full Text] [Related]
36. Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats. Araujo LP; Truzzi RR; Mendes GE; Luz MA; Burdmann EA; Oliani SM Inflamm Res; 2012 Mar; 61(3):189-96. PubMed ID: 22101490 [TBL] [Abstract][Full Text] [Related]
37. Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury. Wadey RM; Pinches MG; Jones HB; Riccardi D; Price SA Toxicol Pathol; 2014; 42(3):591-602. PubMed ID: 23823703 [TBL] [Abstract][Full Text] [Related]
38. The Usefulness of Determining Neutrophil Gelatinase-Associated Lipocalin Concentration Excreted in the Urine in the Evaluation of Cyclosporine A Nephrotoxicity in Children with Nephrotic Syndrome. Gacka E; Życzkowski M; Bogacki R; Paradysz A; Hyla-Klekot L Dis Markers; 2016; 2016():6872149. PubMed ID: 28115789 [No Abstract] [Full Text] [Related]
39. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019 [TBL] [Abstract][Full Text] [Related]
40. The effect of alpha-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity. Lee SY; Jo SK; Cho WY; Kim HK; Won NH Transplantation; 2004 Dec; 78(12):1756-64. PubMed ID: 15614148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]